Normalization of B cell counts and subpopulations after antiretroviral therapy in chronic HIV disease

J Infect Dis. 2008 Feb 15;197(4):572-9. doi: 10.1086/526789.

Abstract

Background: Untreated human immunodeficiency virus (HIV) disease leads to abnormalities in all major lymphocyte populations, including CD4(+) T cells, CD8(+) T cells, and B cells. However, little is known regarding the effect of antiretroviral therapy (ART)-induced decrease in HIV viremia on B cell numbers and subpopulations.

Methods: We conducted a longitudinal study to evaluate changes in B cell numbers and subpopulations that occur during the course of 12 months of effective ART in a group of individuals with chronic HIV infection.

Results: ART-induced decrease in HIV viremia was associated with a significant increase in B cell counts, similar to increases in CD4(+) T cell counts yet distinct from the lack of increase in CD8(+) T cells. The increase in B cell counts was accompanied by a significant decrease in the frequency of apoptosis-prone B cell subpopulations, namely mature activated and immature transitional B cells, which are overrepresented in untreated HIV disease. The increase in B cell counts was reflected by a significant increase in naive and resting memory B cells, both of which represent populations that are essential for generating adequate humoral immunity.

Conclusions: Normalization of B cell counts and subpopulations may help to explain the improvement in humoral immunity reported to occur after an ART-induced decrease in HIV viremia.

Publication types

  • Research Support, N.I.H., Intramural

MeSH terms

  • Adult
  • Anti-Retroviral Agents / pharmacology*
  • B-Lymphocytes / virology*
  • Chronic Disease
  • Female
  • HIV Infections / drug therapy*
  • HIV Infections / immunology
  • Humans
  • Longitudinal Studies
  • Lymphocyte Count
  • Lymphocyte Subsets / drug effects
  • Lymphocyte Subsets / virology*
  • Male
  • Viremia / drug therapy*
  • Viremia / immunology

Substances

  • Anti-Retroviral Agents